Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80,064 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells.
Sun R, Zhang PP, Weng XQ, Gao XD, Huang CX, Wang L, Hu XX, Xu PP, Cheng L, Jiang L, Fu D, Qu B, Zhao Y, Feng Y, Dou HJ, Zheng Z, Zhao WL. Sun R, et al. Among authors: zhao y, zhao wl. Signal Transduct Target Ther. 2022 Mar 18;7(1):80. doi: 10.1038/s41392-022-00895-2. Signal Transduct Target Ther. 2022. PMID: 35301282 Free PMC article.
Clinical efficacy and tumour microenvironment influence of decitabine plus R-CHOP in patients with newly diagnosed diffuse large B-Cell lymphoma: Phase 1/2 and biomarker study.
Zhang MC, Fang Y, Xu PP, Dong L, Shen R, Huang YH, Fu D, Yan ZX, Cheng S, Jiang XF, Song Q, He Y, Zhao Y, Lu M, Ye J, Liu F, Cheng L, Wang CF, Wang L, Zhao WL. Zhang MC, et al. Among authors: zhao y, zhao wl. Clin Transl Med. 2021 Dec;11(12):e584. doi: 10.1002/ctm2.584. Clin Transl Med. 2021. PMID: 34923760 Free PMC article. No abstract available.
80,064 results
You have reached the last available page of results. Please see the User Guide for more information.